Safety and Effectiveness of Emricasan Versus Placebo in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis: An Updated Systematic Review and Meta-Analysis.

IF 2.5 4区医学 Q2 PHARMACOLOGY & PHARMACY

American journal of therapeutics Pub Date : 2025-06-17 DOI:10.1097/MJT.0000000000001971

Mohammad Zamrood Khan, Muzna Murtaza, Zainab Muhammad Hanif, Muhammad Safwan, Haniya Shahid, Khalid Ahmad, Shah Muhammad Zulqarnain, Venjhraj, Mukesh Kumar, Muhammad Ahmed, Abdul Moeed

引用次数: 0

查看原文本刊更多论文

Emricasan与安慰剂在非酒精性脂肪性肝病和/或非酒精性脂肪性肝炎患者中的安全性和有效性：最新的系统评价和荟萃分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American journal of therapeutics PHARMACOLOGY & PHARMACY-

CiteScore

5.50

自引率

9.50%

发文量

142

审稿时长

6-12 weeks

期刊介绍： American Journal of Therapeutics is an indispensable resource for all prescribing physicians who want to access pharmacological developments in cardiology, infectious disease, oncology, anesthesiology, nephrology, toxicology, and psychotropics without having to sift through stacks of medical journals. The journal features original articles on the latest therapeutic approaches as well as critical articles on the drug approval process and therapeutic reviews covering pharmacokinetics, regulatory affairs, pediatric clinical pharmacology, hypertension, metabolism, and drug delivery systems.